Veterinary Intravenous (IV) Solutions Market to Grow with a CAGR of 6.57% through 2028
Rising pet ownership and the increasing surge of veterinary specialization are factors driving the global veterinary intravenous (iv) solutions market in the forecast period 2024-2028.
According to TechSci Research report, “Veterinary Intravenous (IV) Solutions Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Veterinary Intravenous (IV) Solutions Market stood at USD 1.35 billion in 2022 and is anticipated to grow with a CAGR of 6.57% in the forecast period, 2024-2028. Veterinary medicine has evolved from a generalized practice to a field with specialized areas such as cardiology, oncology, and dermatology. These specializations demand targeted treatments, including IV therapies, to address specific health concerns. The development of specialized treatments has expanded the market for veterinary IV solutions.
The livestock and production animal sectors play a critical role in the global food supply. As demand for animal-based products continues to rise, farmers and producers are recognizing the need for better healthcare solutions to ensure the health and productivity of their animals. Veterinary IV solutions are becoming essential tools in managing the health of livestock and production animals. Just like humans, pets are also experiencing an increase in life expectancy due to better healthcare practices and improved living conditions. However, with age comes a higher likelihood of health issues that require medical interventions, including IV therapies. The aging pet population is contributing to the sustained demand for veterinary IV solutions.
Rapid urbanization and changing lifestyles have led to smaller living spaces and limited outdoor access for pets. This often translates to increased health risks, making timely and effective medical interventions crucial. Veterinary IV solutions offer a reliable method of delivering medications and fluids to address various health conditions.
The phenomenon of pet humanization has taken the world by storm. As more households consider their pets as integral members of the family, the demand for advanced healthcare services has increased substantially. Pet owners are more willing to invest in treatments that ensure the health and well-being of their furry companions, including intravenous therapies.
Just as in human medicine, technological advancements are revolutionizing veterinary care. Newer and more efficient IV delivery systems, better monitoring tools, and improved diagnostic techniques are making IV solutions safer and more effective for animals. These technological innovations are driving the adoption of veterinary IV solutions across the globe.
Regulatory bodies across the globe are becoming more focused on ensuring the safety and efficacy of veterinary products, including IV solutions. This increasing scrutiny and regulation provide a conducive environment for the development and commercialization of high-quality veterinary IV solutions.
The Global Veterinary Intravenous (IV) Solutions Market is segmented into Product, Animal Type, Indication, End Use and company.
Based on Product, the isotonic crystalloids segment has emerged as the predominant market leader. In the rapidly evolving landscape of veterinary medicine, isotonic crystalloids have emerged as a dominant force in the global veterinary IV solutions market. Their compatibility with physiology, versatility, electrolyte-balancing capabilities, suitability for emergency care, and minimal side effects position them as a trusted choice for veterinarians worldwide. As the demand for advanced veterinary care continues to rise, isotonic crystalloids are likely to maintain their stronghold in the market, contributing significantly to the well-being and health of our beloved animal companions. Isotonic crystalloids generally have few side effects, making them safer for use in a variety of animal species. This safety profile contributes to their popularity among veterinarians. In emergency situations, quick fluid resuscitation is often essential to stabilize patients. Isotonic crystalloids' ability to swiftly restore blood volume and circulatory stability makes them a frontline choice in critical care scenarios.
Based on region, North America segment is expected to grow during the forecast period. The North American region's supremacy in the global veterinary intravenous solutions market is a culmination of factors ranging from a robust veterinary care infrastructure and technological innovation to rising awareness about animal health and stringent quality assurance. As the demand for advanced veterinary care continues to grow, North America is poised to maintain its dominant position and further drive innovation in the field of veterinary intravenous solutions. The region's commitment to improving animal health and welfare will undoubtedly continue to shape the future of veterinary medicine on a global scale.
The Asia Pacific region is experiencing rapid market growth. Apart from companion animals, Asia Pacific also holds a substantial livestock industry. The increasing demand for safe and efficient veterinary healthcare solutions in livestock production has contributed significantly to the dominance of North America in the veterinary IV solutions market. Farmers and ranchers prioritize animal health and invest in high-quality medical interventions to ensure the productivity and welfare of their livestock.
Major companies
operating in Global Veterinary Intravenous (IV) Solutions Market are:
- Merck & Co., Inc.
- Dechra Veterinary Products
- Sypharma Pty Ltd.
- Animalcare group plc
- Braun SE
- Woods Consulting, LLC
- Baxter International
- Fresenius Kabi
Customers can also request for 10% free customization on this report.
“Veterinary IV solutions have revolutionized the way animals receive medical care, providing essential fluids and medications with precision and efficiency. The global trends in this field indicate a shift toward specialization, technological integration, and nutritional support. While challenges such as access and cost persist, the ongoing advancements and future prospects paint a promising picture for the field of veterinary IV solutions. As these innovations continue to evolve, the quality of care for animals around the world is expected to improve, solidifying the crucial role of IV solutions in the realm of veterinary medicine.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.
“Veterinary Intravenous (IV) Solutions Market By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition), By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others), By Animal type ( Companion Animals, Production Animals), By End Use ( Veterinary Hospitals, Research Institutes, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Veterinary Intravenous (IV) Solutions Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Intravenous (IV) Solutions Market.
Contact
Mr. Ken Mathews
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602